Foghorn Therapeutics Ownership 2024 | Who Owns Foghorn Therapeutics Now?
Institutional Ownership
9.14%
Insider Ownership
19.07%
Retail Ownership
71.79%
Institutional Holders
18.00
Foghorn Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 29.87% | 8.64% | 12,674,120 | - | - | 72,876,191 | Jun 30, 2024 |
| FMR LLC | 15.04% | 0.00% | 6,383,291 | 3,692,155 | 137.20% | 36,703,923 | Jun 30, 2024 |
| BVF INC/IL | 12.50% | 0.85% | 5,302,000 | 5,302,000 | 100.00% | 30,486,500 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5.94% | 0.24% | 2,518,500 | 2,518,500 | 100.00% | 14,481,375 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 5.51% | 0.01% | 2,338,423 | 107,967 | 4.84% | 13,445,932 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 3.71% | 1.14% | 1,573,761 | - | - | 9,049,126 | Jun 30, 2024 |
| BLACKROCK INC. | 3.64% | 0.00% | 1,546,069 | 230,698 | 17.54% | 8,889,898 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.50% | 0.00% | 1,059,485 | -43,008 | -3.90% | 6,092,038 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.70% | 0.11% | 720,720 | - | - | 4,144,140 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.34% | 0.03% | 568,470 | 288,088 | 102.75% | 3,268,703 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.28% | 0.07% | 544,000 | 544,000 | 100.00% | 3,128,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.25% | 0.00% | 531,110 | 82,699 | 18.44% | 3,054,191 | Jun 30, 2024 |
| ALPHABET INC. | 1.18% | 0.15% | 500,901 | - | - | 2,880,181 | Jun 30, 2024 |
| STATE STREET CORP | 1.14% | 0.00% | 482,315 | 44,651 | 10.20% | 2,773,311,000 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.96% | 0.01% | 406,641 | -30,728 | -7.03% | 2,338,186 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.76% | 1.71% | 320,930 | - | - | 1,845,348 | Jun 30, 2024 |
| COLONY GROUP, LLC | 0.51% | 0.00% | 215,690 | 107,920 | 100.14% | 1,294,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.45% | 0.00% | 190,951 | -4,291 | -2.20% | 1,097,968,000 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.43% | 0.00% | 184,304 | -31,966 | -14.78% | 1,059,748 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.29% | 0.19% | 121,672 | - | - | 699,614 | Jun 30, 2024 |
Foghorn Therapeutics's largest institutional shareholder is FLAGSHIP PIONEERING INC., holding 29.87% of the company's total share outstanding, currently valued at $72.88M. The top 10 institutional shareholders own together 81.75% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 29.87% | 8.64% | 12,674,120 | - | - | 72,876,191 | Jun 30, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.76% | 1.71% | 320,930 | - | - | 1,845,348 | Jun 30, 2024 |
| EUCLIDEAN CAPITAL LLC | 3.71% | 1.14% | 1,573,761 | - | - | 9,049,126 | Jun 30, 2024 |
| BVF INC/IL | 12.50% | 0.85% | 5,302,000 | 5,302,000 | 100.00% | 30,486,500 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5.94% | 0.24% | 2,518,500 | 2,518,500 | 100.00% | 14,481,375 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.29% | 0.19% | 121,672 | - | - | 699,614 | Jun 30, 2024 |
| ALPHABET INC. | 1.18% | 0.15% | 500,901 | - | - | 2,880,181 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 1.70% | 0.11% | 720,720 | - | - | 4,144,140 | Jun 30, 2024 |
| ALTA WEALTH ADVISORS LLC | 0.07% | 0.09% | 30,032 | - | - | 172,684 | Jun 30, 2024 |
| ROCKWOOD WEALTH MANAGEMENT, LLC | 0.25% | 0.08% | 107,329 | - | - | 617,142 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.28% | 0.07% | 544,000 | 544,000 | 100.00% | 3,128,000 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.06% | 0.07% | 24,207 | 24,207 | 100.00% | 139,190 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.10% | 0.06% | 41,850 | 41,850 | 100.00% | 240,638 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.34% | 0.03% | 568,470 | 288,088 | 102.75% | 3,268,703 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.06% | 0.02% | 25,567 | -252 | -0.98% | 147,010 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 5.51% | 0.01% | 2,338,423 | 107,967 | 4.84% | 13,445,932 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.14% | 0.01% | 57,500 | 57,500 | 100.00% | 330,625 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.96% | 0.01% | 406,641 | -30,728 | -7.03% | 2,338,186 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.08% | 0.01% | 35,921 | -11,176 | -23.73% | 206,546 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.43% | 0.00% | 184,304 | -31,966 | -14.78% | 1,059,748 | Jun 30, 2024 |
The largest Foghorn Therapeutics shareholder by % of total assets is FLAGSHIP PIONEERING INC.. The company owns 12.67M shares of Foghorn Therapeutics (FHTX), representing 8.64% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 12.50% | 0.85% | 5,302,000 | 5,302,000 | 100.00% | 30,486,500 | Jun 30, 2024 |
| FMR LLC | 15.04% | 0.00% | 6,383,291 | 3,692,155 | 137.20% | 36,703,923 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5.94% | 0.24% | 2,518,500 | 2,518,500 | 100.00% | 14,481,375 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.28% | 0.07% | 544,000 | 544,000 | 100.00% | 3,128,000 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.34% | 0.03% | 568,470 | 288,088 | 102.75% | 3,268,703 | Jun 30, 2024 |
| BLACKROCK INC. | 3.64% | 0.00% | 1,546,069 | 230,698 | 17.54% | 8,889,898 | Jun 30, 2024 |
| RAYMOND JAMES & ASSOCIATES | 5.51% | 0.01% | 2,338,423 | 107,967 | 4.84% | 13,445,932 | Jun 30, 2024 |
| COLONY GROUP, LLC | 0.51% | 0.00% | 215,690 | 107,920 | 100.14% | 1,294,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.25% | 0.00% | 531,110 | 82,699 | 18.44% | 3,054,191 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.14% | 0.01% | 57,500 | 57,500 | 100.00% | 330,625 | Jun 30, 2024 |
| STATE STREET CORP | 1.14% | 0.00% | 482,315 | 44,651 | 10.20% | 2,773,311,000 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.10% | - | 43,789 | 43,789 | 100.00% | 251,787 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.10% | 0.06% | 41,850 | 41,850 | 100.00% | 240,638 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.06% | 0.00% | 25,738 | 25,738 | 100.00% | 147,994 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.06% | 0.07% | 24,207 | 24,207 | 100.00% | 139,190 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.19% | 0.00% | 79,433 | 18,664 | 30.71% | 456,740 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.04% | 0.00% | 17,145 | 17,145 | 100.00% | 98,584 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.06% | - | 26,907 | 14,179 | 111.40% | 154,715 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.16% | 0.00% | 67,866 | 13,903 | 25.76% | 390,230 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 13,587 | 13,587 | 100.00% | 78,125 | Jun 30, 2024 |
As of Jun 30 2024, Foghorn Therapeutics's largest institutional buyer is BVF INC/IL. The company purchased 5.30M stocks of FHTX, valued at $30.49M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| INVESCO LTD. | - | - | - | -56,042 | -100.00% | - | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.50% | 0.00% | 1,059,485 | -43,008 | -3.90% | 6,092,038 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.05% | 0.00% | 21,954 | -40,093 | -64.62% | 126,236 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -36,526 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.43% | 0.00% | 184,304 | -31,966 | -14.78% | 1,059,748 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.96% | 0.01% | 406,641 | -30,728 | -7.03% | 2,338,186 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -21,855 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -13,448 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 7,691 | -12,683 | -62.25% | 44,223 | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -12,474 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.08% | 0.01% | 35,921 | -11,176 | -23.73% | 206,546 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -10,018 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.15% | - | 65,098 | -9,872 | -13.17% | 374,314 | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | - | 13,692 | -5,550 | -28.84% | 79,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.45% | 0.00% | 190,951 | -4,291 | -2.20% | 1,097,968,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.03% | - | 11,053 | -2,985 | -21.26% | 63,555 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,119 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.23% | 0.00% | 98,527 | -1,778 | -1.77% | 566,530 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.02% | - | 7,840 | -1,754 | -18.28% | 45,080 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.00% | - | 1,871 | -551 | -22.75% | 11,000 | Jun 30, 2024 |
As of Jun 30 2024, Foghorn Therapeutics's biggest institutional seller is INVESCO LTD.. The company sold -56.04K shares of FHTX, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BVF INC/IL | 12.50% | 0.85% | 5,302,000 | 5,302,000 | 100.00% | 30,486,500 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5.94% | 0.24% | 2,518,500 | 2,518,500 | 100.00% | 14,481,375 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.28% | 0.07% | 544,000 | 544,000 | 100.00% | 3,128,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.14% | 0.01% | 57,500 | 57,500 | 100.00% | 330,625 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.10% | - | 43,789 | 43,789 | 100.00% | 251,787 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.10% | 0.06% | 41,850 | 41,850 | 100.00% | 240,638 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.06% | 0.00% | 25,738 | 25,738 | 100.00% | 147,994 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.06% | 0.07% | 24,207 | 24,207 | 100.00% | 139,190 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.04% | 0.00% | 17,145 | 17,145 | 100.00% | 98,584 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.03% | 0.00% | 13,587 | 13,587 | 100.00% | 78,125 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.03% | 0.00% | 11,200 | 11,200 | 100.00% | 64,400 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.03% | 0.00% | 10,700 | 10,700 | 100.00% | 61,525 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.02% | 0.00% | 9,762 | 9,762 | 100.00% | 56,132 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 6,940 | 6,940 | 100.00% | 39,905 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 32 | 32 | 100.00% | 184 | Jun 30, 2024 |
Foghorn Therapeutics's largest new institutional shareholder by number of shares is BVF INC/IL, purchased 5.30M shares, valued at $30.49M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| INVESCO LTD. | - | - | - | -56,042 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -36,526 | -100.00% | - | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | - | - | - | -21,855 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -13,448 | -100.00% | - | Jun 30, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | - | - | - | -12,474 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -10,018 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -2,119 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -548 | -100.00% | - | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -151 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
| ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Foghorn Therapeutics's largest sold out institutional shareholder by shares sold is INVESCO LTD., sold -56.04K shares, valued at -, as of undefined.
Foghorn Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY MT VERNON STREET TRUST | 0.05% | 1,404,888 | -56,032 | -3.84% | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.03% | 5,601 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 10,206 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 36,217 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 8,258 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 2,986 | - | - | Mar 31, 2024 |
| Legg Mason ETF Investment Trust | 0.00% | 4,697 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 505 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 884,129 | -198,495 | -18.33% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 109,619 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 55,442 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 25,337 | 4,060 | 19.08% | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 215,973 | 10,442 | 5.08% | Feb 29, 2024 |
| GPS Funds I | 0.00% | 5,017 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 24,810 | - | - | Mar 31, 2024 |
| Managed Portfolio Series | 0.00% | 13,147 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 1,534 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,035 | -919 | -6.59% | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 8,256 | - | - | Mar 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 62,061 | 320 | 0.52% | Feb 29, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,203 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 49,228 | 2,047 | 4.34% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,813 | -2,207 | -24.47% | Mar 31, 2024 |
| Global X Funds | 0.00% | 8,145 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 410 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 18,351 | -1,310 | -6.66% | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,000 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,048 | - | - | Mar 31, 2024 |
| LAZARD FUNDS INC | 0.00% | 2,735 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,335 | 251 | 23.15% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 30,201 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 90,582 | 10,007 | 12.42% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 185 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 721,539 | -42,421 | -5.55% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 46,314 | -349 | -0.75% | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,669 | -19 | -0.52% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,487 | - | - | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 800 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 7,801 | -32 | -0.41% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 2,984 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,074 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 92 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 62,110 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 116 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 42,260 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 158 | -13 | -7.60% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,979 | -2,315 | -43.73% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 12 | - | - | Dec 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,351 | 373 | 18.86% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 10,305 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 7,279 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 784 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 17,400 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,303 | -9 | -0.39% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 4,859 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 9,622 | 21 | 0.22% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 10,456 | 1,620 | 18.33% | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 706 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 6,606 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,526 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 3,591 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 4,034 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 3,290 | 1,095 | 49.89% | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,367 | - | - | Mar 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 265 | 265 | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 4,200 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 2,342 | - | - | Feb 29, 2024 |
Foghorn Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 1.40M shares, compromising 0.05% of its total assets.
Foghorn Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -73.91% |
| 31 Mar, 24 | 69 | 16.95% |
| 31 Dec, 23 | 59 | -3.28% |
| 30 Sep, 23 | 61 | 1.67% |
| 30 Jun, 23 | 60 | -4.76% |
| 31 Mar, 23 | 63 | -5.97% |
| 31 Dec, 22 | 67 | 8.06% |
| 30 Sep, 22 | 62 | 8.77% |
| 30 Jun, 22 | 57 | -5.00% |
| 31 Mar, 22 | 60 | -7.69% |
| 31 Dec, 21 | 65 | 44.44% |
| 30 Sep, 21 | 45 | 21.62% |
| 30 Jun, 21 | 37 | -15.91% |
| 31 Mar, 21 | 44 | -4.35% |
| 31 Dec, 20 | 46 | - |
As of 30 Jun 24, 18 institutions are holding Foghorn Therapeutics's shares, representing a decrease of -73.91% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 3,876,916 | -85.35% |
| 31 Mar, 24 | 26,459,810 | 1.01% |
| 31 Dec, 23 | 26,194,106 | -2.71% |
| 30 Sep, 23 | 26,924,937 | 0.60% |
| 30 Jun, 23 | 26,763,756 | 1.94% |
| 31 Mar, 23 | 26,253,178 | 0.60% |
| 31 Dec, 22 | 26,095,422 | -0.81% |
| 30 Sep, 22 | 26,308,281 | 0.12% |
| 30 Jun, 22 | 26,276,871 | 5.51% |
| 31 Mar, 22 | 24,903,944 | 2.81% |
| 31 Dec, 21 | 24,222,929 | -0.24% |
| 30 Sep, 21 | 24,280,821 | 1.56% |
| 30 Jun, 21 | 23,908,851 | 2.52% |
| 31 Mar, 21 | 23,320,224 | 0.14% |
| 31 Dec, 20 | 23,286,678 | - |
Foghorn Therapeutics (FHTX) has 3.88M shares outstanding as of 30 Jun 24, down -85.35% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 9.14% | 0.23% |
| 31 Mar, 24 | 62.58% | 1.61% |
| 31 Dec, 23 | 62.33% | 1.50% |
| 30 Sep, 23 | 64.37% | 1.57% |
| 30 Jun, 23 | 64.01% | 1.62% |
| 31 Mar, 23 | 62.79% | 1.60% |
| 31 Dec, 22 | 62.74% | 1.57% |
| 30 Sep, 22 | 63.13% | 1.58% |
| 30 Jun, 22 | 63.29% | 1.75% |
| 31 Mar, 22 | 60.20% | 1.42% |
| 31 Dec, 21 | 65.17% | 1.51% |
| 30 Sep, 21 | 65.67% | 1.56% |
| 30 Jun, 21 | 64.89% | 1.62% |
| 31 Mar, 21 | 63.34% | 0.45% |
| 31 Dec, 20 | 118.63% | - |
As of 30 Jun 24, Foghorn Therapeutics is held by 9.14% institutional shareholders, representing a 0.23% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -71.43% |
| 31 Mar, 24 | 28 | 16.67% |
| 31 Dec, 23 | 24 | 26.32% |
| 30 Sep, 23 | 19 | -24.00% |
| 30 Jun, 23 | 25 | 8.70% |
| 31 Mar, 23 | 23 | -30.30% |
| 31 Dec, 22 | 33 | 22.22% |
| 30 Sep, 22 | 27 | -3.57% |
| 30 Jun, 22 | 28 | - |
| 31 Mar, 22 | 28 | -20.00% |
| 31 Dec, 21 | 35 | 75.00% |
| 30 Sep, 21 | 20 | -13.04% |
| 30 Jun, 21 | 23 | 53.33% |
| 31 Mar, 21 | 15 | -67.39% |
| 31 Dec, 20 | 46 | - |
8 institutional shareholders have increased their position in FHTX stock as of 30 Jun 24 compared to 28 in the previous quarter (a -71.43% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 3 | -83.33% |
| 31 Mar, 24 | 18 | 5.88% |
| 31 Dec, 23 | 17 | -10.53% |
| 30 Sep, 23 | 19 | 26.67% |
| 30 Jun, 23 | 15 | -6.25% |
| 31 Mar, 23 | 16 | 33.33% |
| 31 Dec, 22 | 12 | -25.00% |
| 30 Sep, 22 | 16 | 14.29% |
| 30 Jun, 22 | 14 | -36.36% |
| 31 Mar, 22 | 22 | 37.50% |
| 31 Dec, 21 | 16 | 14.29% |
| 30 Sep, 21 | 14 | 366.67% |
| 30 Jun, 21 | 3 | -76.92% |
| 31 Mar, 21 | 13 | - |
| 31 Dec, 20 | - | - |
3 institutional shareholders have reduced their position in FHTX stock as of 30 Jun 24 compared to 18 in the previous quarter (a -83.33% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 18 | -73.91% | 3,876,916 | -85.35% | 9.14% | 0.23% | 8 | -71.43% | 3 | -83.33% |
| 31 Mar, 24 | 69 | 16.95% | 26,459,810 | 1.01% | 62.58% | 1.61% | 28 | 16.67% | 18 | 5.88% |
| 31 Dec, 23 | 59 | -3.28% | 26,194,106 | -2.71% | 62.33% | 1.50% | 24 | 26.32% | 17 | -10.53% |
| 30 Sep, 23 | 61 | 1.67% | 26,924,937 | 0.60% | 64.37% | 1.57% | 19 | -24.00% | 19 | 26.67% |
| 30 Jun, 23 | 60 | -4.76% | 26,763,756 | 1.94% | 64.01% | 1.62% | 25 | 8.70% | 15 | -6.25% |
| 31 Mar, 23 | 63 | -5.97% | 26,253,178 | 0.60% | 62.79% | 1.60% | 23 | -30.30% | 16 | 33.33% |
| 31 Dec, 22 | 67 | 8.06% | 26,095,422 | -0.81% | 62.74% | 1.57% | 33 | 22.22% | 12 | -25.00% |
| 30 Sep, 22 | 62 | 8.77% | 26,308,281 | 0.12% | 63.13% | 1.58% | 27 | -3.57% | 16 | 14.29% |
| 30 Jun, 22 | 57 | -5.00% | 26,276,871 | 5.51% | 63.29% | 1.75% | 28 | - | 14 | -36.36% |
| 31 Mar, 22 | 60 | -7.69% | 24,903,944 | 2.81% | 60.20% | 1.42% | 28 | -20.00% | 22 | 37.50% |
| 31 Dec, 21 | 65 | 44.44% | 24,222,929 | -0.24% | 65.17% | 1.51% | 35 | 75.00% | 16 | 14.29% |
| 30 Sep, 21 | 45 | 21.62% | 24,280,821 | 1.56% | 65.67% | 1.56% | 20 | -13.04% | 14 | 366.67% |
| 30 Jun, 21 | 37 | -15.91% | 23,908,851 | 2.52% | 64.89% | 1.62% | 23 | 53.33% | 3 | -76.92% |
| 31 Mar, 21 | 44 | -4.35% | 23,320,224 | 0.14% | 63.34% | 0.45% | 15 | -67.39% | 13 | - |
| 31 Dec, 20 | 46 | - | 23,286,678 | - | 118.63% | - | 46 | - | - | - |
Foghorn Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Foghorn Therapeutics's stock was made by Cavalie Fanny on Mar 12 2024, selling 11,000 shares at $6.56 per share (valued at $72.13K). The last insider buy of FHTX was made by Flagship Pioneering Inc. on May 24 2024, buying 1,814,915 shares at - per share (worth $181.49).
Foghorn Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 11 | - | - |
| Q1 2024 | 6 | 1 | 600.00% |
| Q4 2023 | 1 | - | - |
| Q3 2023 | 3 | 3 | 100.00% |
| Q2 2023 | 9 | 1 | 900.00% |
| Q1 2023 | 9 | 2 | 450.00% |
| Q4 2022 | 2 | 1 | 200.00% |
| Q3 2022 | 3 | 13 | 23.08% |
| Q2 2022 | 12 | 1 | 1200.00% |
| Q1 2022 | 5 | 17 | 29.41% |
| Q4 2021 | 1 | 3 | 33.33% |
| Q3 2021 | 9 | 1 | 900.00% |
| Q2 2021 | 2 | 3 | 66.67% |
| Q1 2021 | 4 | - | - |
| Q4 2020 | 13 | 29 | 44.83% |
11 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Foghorn Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | - | - |
| Q1 2024 | - | 1 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 5 | - | - |
As of Q2 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of Foghorn Therapeutics's stocks.
Foghorn Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| NRIX | Nurix Therapeutics, Inc. |
| CYT | Cyteir Therapeutics, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| PRLD | Prelude Therapeutics Incorporated |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| CSBR | Champions Oncology, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| MNOV | MediciNova, Inc. |
| RZLT | Rezolute, Inc. |
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MOLN | Molecular Partners AG |
| STTK | Shattuck Labs, Inc. |
FHTX Ownership FAQ
Who Owns Foghorn Therapeutics?
Foghorn Therapeutics is owned by institutional shareholders (9.14%), insiders (19.07%), and public (71.79%). The largest institutional shareholder of Foghorn Therapeutics is FLAGSHIP PIONEERING INC. (29.87% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.05% of total shares).
Who are the major institutional shareholders of Foghorn Therapeutics?
Foghorn Therapeutics's major institutional shareholders are FLAGSHIP PIONEERING INC., FMR LLC, BVF INC/IL, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and RAYMOND JAMES & ASSOCIATES. The top five shareholders own together 68.86% of the company's share outstanding.
How many Foghorn Therapeutics shareholders are there?
As of Jun 2024, there are 18 institutional shareholders of Foghorn Therapeutics.
What percentage of Foghorn Therapeutics is owned by FLAGSHIP PIONEERING INC?
FLAGSHIP PIONEERING INC owns 12.67M shares of Foghorn Therapeutics, representing 29.87% of the company's total shares outstanding, valued at $72.88M (as of Jun 2024).
What percentage of Foghorn Therapeutics is owned by FMR LLC?
As of Jun 2024, FMR LLC holds 6.38M shares of Foghorn Therapeutics (FHTX), compromising 15.04% of the company, valued at $36.7M.
What percentage of Foghorn Therapeutics is owned by BVF INC/IL?
BVF INC/IL is the third largest holder of Foghorn Therapeutics. The company owns 5.3M of the company's shares outstanding (worth $30.49M).